SCHEMBL3851626

SCHEMBL3851626

Fc1ccc(-c2n[nH]cc2-c2cc(Cl)c3ncc(-c4ccccn4)n3c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 4/20 0.38
MAPK14 Q16539 1/20 0.38
AKT1 P31749 2/20 0.35
AKT2 P31751 2/20 0.35
NPY5R Q15761 1/20 0.34
NOTUM Q6P988 1/20 0.34
TP53 P04637 1/20 0.34
GAA P10253 1/20 0.34
SQOR Q9Y6N5 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
PAX8 Q06710 1/20 0.33
DCTPP1 Q9H773 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
NFKB1 P19838 1/20 0.32
RAB9A P51151 1/20 0.32
NFKB2 Q00653 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5853473 0.99 TGFBR1 (0.37) TGFBR1MAPK14AKT1AKT2NPY5R
SCHEMBL3846558 0.83 TGFBR1 (0.44) TGFBR1MAPK14TP53GAAMAPT
Hydrochloric Acid SCHEMBL3855523 0.82 KDR (0.36) SMN1; SMN2MEN1NPC1MAPTNFKB1
SCHEMBL3847277 0.80 SMN1; SMN2 (0.36) TGFBR1MAPK14AKT1AKT2TP53
SCHEMBL7856946 0.74 TGFBR1 (0.51) TGFBR1MAPK14NPY5RSQORSMN1; SMN2
SCHEMBL13874280 0.74 FLT3 (0.49) TGFBR1MAPK14KDM4ENPC1MAPT
SCHEMBL3855569 0.73 TGFBR1 (0.50) TGFBR1
SCHEMBL5490810 0.73 TGFBR1 (0.54) TGFBR1MAPK14NPY5RSQORDCTPP1
Hydrochloric Acid SCHEMBL3846111 0.73 FLT3 (0.48) TGFBR1MAPK14KDM4ENPC1MAPT
SCHEMBL3850617 0.72 FLT3 (0.41) TGFBR1MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed